Clinical Study

Vinpocetine and Pyritinol: A New Model for Blood Rheological Modulation in Cerebrovascular Disorders—A Randomized Controlled Clinical Study

Table 3

Dual combined effects of vinpocetine and pyritinol on hemorheological parameters in cerebrovascular disorders.

VariablesBeforeAfter value

Hematocrit %45.7 ± 0.2343.1 ± 0.65
Total serum protein g/dl8.64 ± 0.218.12 ± 2.76
Fibrinogen g/l3.78 ± 0.871.99 ± 0.09
Relative blood viscosity cP4.33 ± 0.651.98 ± 0.02
Actual blood viscosity cP3.3685 ± 0.0211.0185 ± 0.45
WBV-HSR cP6.6009 ± 0.0325.172 ± 0.026
WBV-LSR cP116.377 ± 0.16581.45918 ± 2.23
RRI2.17 ± 0.0111.75 ± 0.03
Plasma viscosity cP1.55 ± 0.060.58 ± 0.006
Kinematic viscosity3.18 ± 0.170.960 ± 0.002

WBV-HSR: whole blood viscosity high shear rate, WBV-LSR: whole blood viscosity low shear rate, and RRI: RBC rigidity index.